Evolution of our Cloning Strategy

By Alex and Thanushi

Initial design concept

-

Initially wanted to follow GAPTrap paper to the T

Use GAPTrap – mCherry- IRES- Hygro as backbone

Clone in sACE 2 from twist plasmid using AscI and SalI digestion

Form GAPTrap guide RNA and Cas 9 mRNA

Electroporate into iPSC

CRISPR consideration

-

Changed to Geng et al.’s CRISPR method and considered lipofectamine

Form guide RNA dimer

Clone into a Addgene’s PX459V2.0-eSpCas9 plasmid (#108292) by BbsI digestion

Lipofectamine transfection

Ed Stanley Consultation

-

Met with Ed Stanley July 24th

Suggested using GAPTrap- mtagtdTom-IRES-Muro

Change antibiotic resistance of ACE 2 plasmid to kanamycin/chloramphenicol

Check Restriction enzyme cut sites

Will provide us with TALENs plasmids

Suggested using electroporation instead of lipofectamine

Request for more bacteria when ordering plasmids so we don’t have to grow them up ourselves

Nadia Consultation

-

Should we transfect macrophages or transfect iPSCs then differentiate them into macrophages afterwards?

Use Nadia’s protocol for differentiating iPSCs to macrophages after they’ve been transfected and verified

Gibson Assembly

-

But Gibson assembly requires fragments of >200 nucleotides

So if we did use Gibson, would need to order constructs of T2A-ACE2-tag and P2A-tdTom

Decided instead to order them as a single synthesised construct using the sponsorship from Twist

Later on, we can use Gibson to rearrange order of cistrons and see how that affects expression levels